My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
295.54
+1.42 (+0.48%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 7, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amgen
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
58
59
Next >
7 Cheap Biotech Stocks With Major Upside Potential
July 09, 2024
While the broader healthcare sector enjoys permanent relevance, you can potentially maximize your upside with cheap biotech stocks.
Via
InvestorPlace
Eli Lilly Rose More Than 50% So Far This Year. Can It Soar Past $1,000 in the 2nd Half?
July 09, 2024
This pharma company is posting double-digit revenue growth.
Via
The Motley Fool
3 Small-Cap Stocks With Explosive 2X Growth Potential
July 08, 2024
Discover three top high-growth small-cap stocks, fueled by potential rate cuts and promising prospects in the second half of 2024.
Via
InvestorPlace
3 Dividend Stocks Crushing the S&P 500 With 30%+ Annual Total Returns
July 08, 2024
With technology growth stocks propelling the S&P 500, dividend stocks have often found themselves playing catch-up. But not these three.
Via
InvestorPlace
Topics
Stocks
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO
July 07, 2024
The GLP-1 drug market for obesity treatment is expected to skyrocket to $1 trillion or more, according to Maurits Pot, founder and CEO of Tema ETFs.
Via
Benzinga
Topics
ETFs
What the Options Market Tells Us About Amgen
July 02, 2024
Via
Benzinga
Amgen Unusual Options Activity
July 01, 2024
Via
Benzinga
Can Amgen Stock Keep Trouncing the S&P 500?
June 27, 2024
Amgen's market-beating ways are unlikely to evaporate any time soon.
Via
The Motley Fool
Topics
Stocks
Week In Review: Samsung Biologics Signs $1 Billion Manufacturing Contract With US Biopharma
July 06, 2024
Samsung Biologics, a Korean CDMO, signed a $1.06 billion agreement to provide manufacturing services for an unnamed US pharma. The agreement is the largest that Samsung Bio has made since it was...
Via
Talk Markets
What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients
July 05, 2024
A number of companies are working on new drugs for high lipids, including cholesterol and triglycerides.
Via
Investor's Business Daily
Amgen, Inc. Dividend Stock Analysis
July 05, 2024
Amgen Inc. is one of the world's leading biotech companies with major treatments for anemia, neutropenia, rheumatoid and psoriatic arthritis, psoriasis, cancer and osteoporosis.
Via
Talk Markets
The 3 Best Healthcare Stocks to Buy in July 2024
July 04, 2024
Consistent breakthroughs, improved products and relatively consistent growth make these the best healthcare stocks to buy.
Via
InvestorPlace
Forget Eli Lilly: 3 Biotech Stocks to Buy Instead
July 04, 2024
Eli Lilly is a good stock to buy, but these should be even better.
Via
The Motley Fool
Smart Money Is Betting Big In AMGN Options
June 25, 2024
Via
Benzinga
Where Will Amgen Be in 5 Years?
June 20, 2024
Can Amgen be a market-beating stock?
Via
The Motley Fool
Check Out What Whales Are Doing With AMGN
June 18, 2024
Via
Benzinga
S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
July 03, 2024
The S&P 500 and Nasdaq 100 indices surged to new all-time highs on Thursday, as investors heightened their expectations for rate cuts following June’s sharply lower-than-expected services sector...
Via
Benzinga
Topics
Economy
Stocks
Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
July 02, 2024
The biotech sector (IBB) is trading just 3% away from its 52-week high and a significant resistance level, suggesting a potential breakout.
Via
MarketBeat
Topics
ETFs
1 Dividend Growth Stock to Buy and Hold for 10 Years
June 29, 2024
This company's payouts look safe.
Via
The Motley Fool
Expert Ratings For Amgen
June 14, 2024
Via
Benzinga
10 Blue-Chip Dividend Growth Stocks With 3% Yields And Safe Dividends
June 28, 2024
A look at 10 blue-chip dividend growth stocks with yields above 3%, the opportunity for those yields to continue growing in the future, and where we can be very certain that the dividend is safe.
Via
Talk Markets
These Are The Best Dow Jones Stocks Of 2024 Thus Far
June 27, 2024
The AI boom helped to produce two best Dow Jones stocks, including newbie Amazon.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Stocks
Tech Is Consolidating And The Market’s Seeking New Leadership
June 25, 2024
The tape tells the tale, just like it always does: The tech sector is clearly in consolidation mode right now.
Via
Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
June 24, 2024
Via
Benzinga
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
June 21, 2024
Gilead Sciences faces Wall Street speculation about its potential in the obesity drug market despite its focus on liver treatments.
Via
Benzinga
Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033
June 20, 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:KYMR),(NASDAQ:GILD),(OTCQX:RHHBY),(NASDAQ:AMGN) EQNX::TICKER_END
Via
FinancialNewsMedia
Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033
June 20, 2024
From
FN Media Group LLC
Via
GlobeNewswire
7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline
June 17, 2024
With biotech stocks enjoying a permanently relevant narrative, investors should focus on these compelling opportunities.
Via
InvestorPlace
Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines
June 17, 2024
Biotechnology firm Moderna Inc. (NASDAQ: MRNA) made mainstream headlines during the pandemic for its COVID-19 vaccines. Moderna is focused on messenger RNA
Via
MarketBeat
Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
June 13, 2024
The companies are closing in on the finish line for two new COPD treatments.
Via
Investor's Business Daily
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
58
59
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.